1. Reperfusion therapy for acute ischemic stroke in older people: An observational real‐life study
- Author
-
Emmanuelle Duron, Nicolas Legris, Alexandra Rouquette, Nicolas Chausson, Mariana Sarov, Didier Smadja, François Lun, Claire Ancelet, Laura Venditti, Christiane Verny, Olivier Chassin, Justine Sudre, Olga Laine, Laurent Spelle, and Christian Denier
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Comorbidity ,Severity of Illness Index ,law.invention ,Reperfusion therapy ,Randomized controlled trial ,law ,Modified Rankin Scale ,Internal medicine ,medicine ,Humans ,Thrombolytic Therapy ,Prospective Studies ,Prospective cohort study ,Stroke ,Aged ,Ischemic Stroke ,Thrombectomy ,Aged, 80 and over ,Intracerebral hemorrhage ,business.industry ,Age Factors ,Odds ratio ,Thrombolysis ,Middle Aged ,medicine.disease ,Treatment Outcome ,Reperfusion ,Female ,Geriatrics and Gerontology ,business - Abstract
BACKGROUND While randomized clinical trials have shown the benefit of thrombolysis and endovascular thrombectomy (EVT) in patients with acute ischemic stroke (AIS), we aimed to describe in a real-life study the differences between older (>80 years old) and younger patients treated for AIS. METHODS Thousand patients treated with thrombolysis and/or EVT were consecutively included in a prospective monocentric database (admitted from December 2015 to May 2019 in our comprehensive stroke center). Demographic data with detailed history, baseline physical examinations and treatments, laboratory and imaging data, prestroke functional status, and outcome 3 months after stroke were analyzed. RESULTS Older patients (n = 357) had more baseline comorbidities and lower levels of prestroke independence (modified Rankin scale ≤2; 67.2% vs. 96.1%) and more severe strokes (median National Institute of Health Stroke Score [NIHSS] 15 vs. 12; p
- Published
- 2021